Insulin efsitora alfa

Modify Date: 2025-11-28 15:20:31

Insulin efsitora alfa Structure
Insulin efsitora alfa structure
Common Name Insulin efsitora alfa
CAS Number 2131038-11-2 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Insulin efsitora alfa


Insulin efsitora alfa (LY-3209590) is a selective agonist of insulin receptor (IR). Insulin efsitora alfa is a fusion protein composed of human IR agonists fused with the crystallizable (Fc) domain of human immunoglobulin G2 (IgG2) fragment, with a molecular weight of 64.1 kDa. Insulin efsitora alfa is well tolerated and has potential applications in diabetes patients[1].

 Names

Name Insulin efsitora alfa

 Insulin efsitora alfa Biological Activity

Description Insulin efsitora alfa (LY-3209590) is a selective agonist of insulin receptor (IR). Insulin efsitora alfa is a fusion protein composed of human IR agonists fused with the crystallizable (Fc) domain of human immunoglobulin G2 (IgG2) fragment, with a molecular weight of 64.1 kDa. Insulin efsitora alfa is well tolerated and has potential applications in diabetes patients[1].
Related Catalog
In Vitro Insulin efsitora alfa (0.01-100 nM) 在 HEK293 细胞中刺激人胰岛素受体同种型 A (hIR-A) 和人胰岛素受体亚型 B (hIR-B) 磷酸化,EC50 值分别为 4241 nM和 391 nM[2]。 Insulin efsitora alfa (20 µM;30 min) 显著促进 hIR-A 和 hIR-B 去磷酸化[2]。 Insulin efsitora alfa 刺激 3T3-L1 脂肪细胞的脂质生成和 SAOS-2 与 H4IIE 细胞的细胞增殖,EC50 值分别为 19 nM、134 nM 和 20 nM[2]。
In Vivo Insulin efsitora alfa (3、10 和 30 nmol/kg;皮下注射;单剂量) 在使用链脲佐菌素 (Streptozotocin,HY-13753) 治疗的糖尿病大鼠中显著降低了血糖[2]。
References

[1]. Heise T, et al. Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once-weekly dosing for the treatment of patients with diabetes. Diabetes Obes Metab. 2023 Apr;25(4):1080-1090.  

[2]. Moyers JS, et al. Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein. J Pharmacol Exp Ther. 2022 Sep;382(3):346-355.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
insulin aspart
116094-23-6
Insulin, des(pentapeptide)(B1-B5)-
76530-09-1
insulin-like growth factor 1, des-(1-3)-
112603-35-7
insulin, despentapeptide(B26-B30)-
55599-09-2
Insulin from porcine pancreas
12584-58-6
Insulin Detemir
169148-63-4
insulin, deshexapeptide(B25-B30)-
39471-22-2
insulin, despentapeptide (B26-B30)-TyrNH2(B25)-
103370-34-9
insulin, desoctapeptide-
39416-70-1
N-(3-chloro-2-methylphenyl)-1-methyl-2-oxo-2,4,5,6-tetrahydro-1H-pyrrolo[3,2,1-ij]quinoline-8-sulfonamide
898455-15-7
N-benzhydryl-1-methyl-2-oxo-2,4,5,6-tetrahydro-1H-pyrrolo[3,2,1-ij]quinoline-8-sulfonamide
898427-31-1
N-(2-chlorophenyl)-3-methyl-2-oxo-1-azatricyclo[6.3.1.0^{4,12}]dodeca-4,6,8(12)-triene-6-sulfonamide
898427-32-2
N-(3-chloro-4-methylphenyl)-1-methyl-2-oxo-2,4,5,6-tetrahydro-1H-pyrrolo[3,2,1-ij]quinoline-8-sulfonamide
898411-70-6
N-(3,4-dichlorophenyl)-1-methyl-2-oxo-2,4,5,6-tetrahydro-1H-pyrrolo[3,2,1-ij]quinoline-8-sulfonamide
898455-19-1
N-(5-chloro-2-methylphenyl)-1-methyl-2-oxo-2,4,5,6-tetrahydro-1H-pyrrolo[3,2,1-ij]quinoline-8-sulfonamide
898427-33-3
N-(4-(1-methyl-2-oxo-2,4,5,6-tetrahydro-1H-pyrrolo[3,2,1-ij]quinoline-8-sulfonamido)phenyl)acetamide
903270-31-5
N-(4-methoxy-3-{3-methyl-2-oxo-1-azatricyclo[6.3.1.0^{4,12}]dodeca-4,6,8(12)-triene-6-sulfonamido}phenyl)acetamide
903363-40-6
2-(1-methyl-2-oxo-2,4,5,6-tetrahydro-1H-pyrrolo[3,2,1-ij]quinoline-8-sulfonamido)benzamide
898411-72-8
N1-benzyl-N2-(3-oxo-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinolin-9-yl)oxalamide
898427-62-8